Abbott Toxicology Tcup Clia Waived Test

The Abbott Toxicology Tcup is a comprehensive, multi-panel device designed to screen for 14 different drug classes and metabolites.

The test panel includes screening for the following substances, in addition to testing for Creatinine (CR), pH (PH), and Specific Gravity (SG) indicators:

• AMP1000 (Amphetamines)
• BAR300 (Barbiturates)
• BUP10 (Buprenorphine)
• BZO300 (Benzodiazepines)
• COC3000 (Cocaine)
• MDMA500 (Ecstasy/Methylenedioxymethamphetamine)
• MET1000 (Methamphetamine)
• MTD300 (Methadone)
• MOP(OPI300) (Opiates/Morphine)
• OXY100 (Oxycodone)
• PCP25 (Phencyclidine)
• PPX300 (Propoxyphene)
• TCA1000 (Tricyclic Antidepressants)
• THC50 (Tetrahydrocannabinol/Marijuana)

Yes, the Abbott Toxicology Tcup is CLIA Waived.

This status is a significant advantage, as it simplifies regulatory compliance, making the test ideal for point-of-care testing (POCT) environments, such as clinical settings or workplace drug screening programs. The Tcup format also ensures efficient and easy use for sample collection and rapid screening.

Each box of Abbott Toxicology Tcup Clia Waived Tests contains 25 individual tests.

The Abbott Toxicology Tcup CLIA Waived Test is designed to accurately detect THC at a cutoff level of 50 ng/mL.

The Abbott Toxicology Tcup CLIA Waived Test detects Cocaine (COC) with a precise cutoff level of 3000 ng/mL.

Yes, the Tcup format is designed to be highly convenient and easy to use, especially in clinical or workplace testing environments. Its all-in-one nature streamlines the entire screening process.

Key benefits of the Tcup design include:

• Integrated Collection and Testing: The device combines sample collection and diagnostic testing into one unit, simplifying the workflow.
• Efficient Workflow: This format is intended for rapid screening and obtaining preliminary positive results quickly.
• CLIA Waived: The device is certified as CLIA Waived, which simplifies regulatory requirements for various point-of-care settings.

Yes, the Abbott Toxicology Tcup test includes validity indicators to help ensure the integrity of the sample during screening.

This device provides results for three key indicators:

• Creatinine (CR)
• pH (PH)
• Specific Gravity (SG)

These checks offer an important assurance that the specimen is suitable for producing accurate drug screening results.

The Abbott Toxicology Tcup is designated as CLIA Waived, which significantly simplifies regulatory compliance for point-of-care testing. This makes it ideal for use in various professional environments, including:

• Clinical settings (e.g., medical facilities or doctor’s offices)
• Workplace drug testing programs
• Any environment requiring efficient, CLIA Waived screening devices

Yes, the Abbott Toxicology Tcup is manufactured in the US.

This toxicology test is comprehensive because it is capable of screening for thirteen different drug classes and metabolites simultaneously. It includes detection for:

• AMP1000
• BAR300
• BUP10
• BZO300
• COC3000
• MDMA500
• MET1000
• MTD300
• MOP(OPI300)
• OXY100
• PCP25
• PPX300
• TCA1000
• THC50

Additionally, it provides CR, PH, and SG indicators for concentration, pH, and specific gravity, which helps confirm sample validity.